International News Portal21 November 2026Headlines from established publishers
World
Biotech CEO says the US is fighting fentanyl ‘all wrong,’ urges new Democratic Congress to step up
Nearly a year after President Donald Trump designated illicit fentanyl a weapon of mass destruction, ARMR Sciences' CEO says treat it like a bioweapon.
WASHINGTON — America is approaching the fentanyl crisis "all wrong" by waiting to reverse overdoses after they begin instead of blocking the drug with an experimental fentanyl vaccine, ARMR Sciences CEO Collin Gage told Fox News Digital.
In an exclusive interview, Gage urged the new incoming Democrat-controlled Congress to build on President Donald Trump's designation of illicit fentanyl as a weapon of mass destruction and treat emerging synthetic drugs as a biodefense priority.
"If you look at the overdose crisis like any other health crisis, really as a disease, you'll know the best way to treat a crisis is by preventing it altogether," Gage said. "We need to completely overhaul the treatment paradigm and focus on preventing these deaths with new innovative therapeutics, rather than continuing the same approach that historically has led to tens of thousands of deaths, hundreds of thousands of deaths over the last several years."
Gage pointed to President Donald Trump's designation of illicit fentanyl as a weapon of mass destruction as "absolutely critical" to shifting Washington toward a biodefense strategy.
Gage says emerging synthetic drugs pose a distinct biological threat, unlike traditional chemical or biological weapons, because anyone can rapidly produce them using the dark web.
"People often don't realize this, but fentanyl, carfentanil, nitazenes, medetomidine—all of these emerging synthetic drug threats are unique biothreats in that they're not like sarin gas, they're not like anthrax," Gage told Fox News Digital. "You can't go on the dark web and quickly formulate those substances. You can do that with these pharmaceutical-based agents that have completely caused havoc within the United States, and we're now starting to see that spread globally."
ARMR Sciences is currently running a Phase 1/2 clinical trial to evaluate the safety of its experimental fentanyl vaccine and measure how effectively it blocks synthetic threats from reaching the brain.
Rather than waiting for an overdose to begin, Gage explained how the technology works:
With a new Democrat-controlled Congress preparing to take office, Gage urged lawmakers to treat synthetic drug defense as a "red, white and blue" priority rather than a partisan issue, noting that fentanyl "does not discriminate" by race or socioeconomic status.
Before expanding beyond the military to protect high-risk civilians like college students, Gage said safety and transparency must come first.
ARMR Sciences publishes its full formulation on its website and intentionally left out heavy metals—a move Gage tied to Health and Human Services Secretary Robert F. Kennedy Jr.'s push to scrutinize ingredients, while also praising former Rep. Patrick Kennedy's efforts to overhaul addiction treatment facilities.
For Gage, whose mother struggled with addiction and who has lost friends to overdoses, the mission is deeply personal.
"Passion is born from internal suffering," Gage said. "No family should look over and see an empty chair at the dinner table. No kid should be hiding in their room because they're scared if a parent is suffering from an addiction issue. I want to prevent that happening from any American across the country. "
If you or someone you know is struggling with substance use, help is available 24/7 through the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 1-800-662-4357.
We use cookies to run this site and, with your consent, to measure
traffic and improve our content. Necessary cookies are always on. You
can accept all cookies or choose which ones to allow.
Privacy policy.